Appointment of Joint Corporate Broker
Aptamer Group plc has appointed Cavendish Capital Markets Limited as Joint Corporate Broker, effective immediately, to work alongside existing broker Turner Pope Investments. This strategic move aims to expand research coverage and enhance institutional engagement, leveraging Cavendish's expertise in the healthcare and life sciences sectors as Aptamer advances its therapeutic programmes.
Select text to share a quote on X · sign in to keep highlights & notes in your APTA notes
Aptamer Group plc (AIM: APTA), the developer of next-generation synthetic Optimer® binders, is pleased to announce the appointment of Cavendish Capital Markets Limited ("Cavendish") as Joint Corporate Broker to the Company with immediate effect.
Cavendish will work alongside Turner Pope Investments (TPI) Limited, which will continue to act as Joint Corporate Broker.
As Aptamer continues to advance its therapeutic programmes, the appointment is intended to broaden research coverage and institutional engagement, drawing on Cavendish's specialist healthcare expertise and established relationships within the life sciences sector.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.